Logo image of NHI

NATL HEALTH INVESTORS INC (NHI) Stock Fundamental Analysis

NYSE:NHI - New York Stock Exchange, Inc. - US63633D1046 - REIT - Currency: USD

72.685  -0.75 (-1.03%)

Fundamental Rating

5

Taking everything into account, NHI scores 5 out of 10 in our fundamental rating. NHI was compared to 129 industry peers in the Diversified REITs industry. NHI has an excellent profitability rating, but there are some minor concerns on its financial health. While showing a medium growth rate, NHI is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

8

1. Profitability

1.1 Basic Checks

NHI had positive earnings in the past year.
In the past year NHI had a positive cash flow from operations.
NHI had positive earnings in each of the past 5 years.
In the past 5 years NHI always reported a positive cash flow from operatings.
NHI Yearly Net Income VS EBIT VS OCF VS FCFNHI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M 200M -200M

1.2 Ratios

With an excellent Return On Assets value of 5.07%, NHI belongs to the best of the industry, outperforming 93.80% of the companies in the same industry.
NHI's Return On Equity of 9.89% is amongst the best of the industry. NHI outperforms 87.60% of its industry peers.
The Return On Invested Capital of NHI (5.56%) is better than 93.80% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for NHI is above the industry average of 3.15%.
The last Return On Invested Capital (5.56%) for NHI is above the 3 year average (5.45%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 5.07%
ROE 9.89%
ROIC 5.56%
ROA(3y)4.46%
ROA(5y)4.65%
ROE(3y)8.71%
ROE(5y)9.16%
ROIC(3y)5.45%
ROIC(5y)5.5%
NHI Yearly ROA, ROE, ROICNHI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2 4 6 8 10

1.3 Margins

NHI has a Profit Margin of 41.13%. This is amongst the best in the industry. NHI outperforms 91.47% of its industry peers.
NHI's Profit Margin has declined in the last couple of years.
With an excellent Operating Margin value of 55.64%, NHI belongs to the best of the industry, outperforming 95.35% of the companies in the same industry.
In the last couple of years the Operating Margin of NHI has declined.
Looking at the Gross Margin, with a value of 84.22%, NHI belongs to the top of the industry, outperforming 86.05% of the companies in the same industry.
In the last couple of years the Gross Margin of NHI has declined.
Industry RankSector Rank
OM 55.64%
PM (TTM) 41.13%
GM 84.22%
OM growth 3Y-3.37%
OM growth 5Y-4.05%
PM growth 3Y3.19%
PM growth 5Y-4%
GM growth 3Y-4.37%
GM growth 5Y-3.06%
NHI Yearly Profit, Operating, Gross MarginsNHI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60 80

5

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so NHI is destroying value.
Compared to 1 year ago, NHI has more shares outstanding
NHI has more shares outstanding than it did 5 years ago.
The debt/assets ratio for NHI has been reduced compared to a year ago.
NHI Yearly Shares OutstandingNHI Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M
NHI Yearly Total Debt VS Total AssetsNHI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

2.2 Solvency

Based on the Altman-Z score of 1.74, we must say that NHI is in the distress zone and has some risk of bankruptcy.
NHI has a Altman-Z score of 1.74. This is amongst the best in the industry. NHI outperforms 94.57% of its industry peers.
A Debt/Equity ratio of 0.89 indicates that NHI is somewhat dependend on debt financing.
With a decent Debt to Equity ratio value of 0.89, NHI is doing good in the industry, outperforming 65.89% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.89
Debt/FCF N/A
Altman-Z 1.74
ROIC/WACC0.71
WACC7.82%
NHI Yearly LT Debt VS Equity VS FCFNHI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M 1B 1.5B

2.3 Liquidity

NHI has a Current Ratio of 3.23. This indicates that NHI is financially healthy and has no problem in meeting its short term obligations.
NHI has a Current ratio of 3.23. This is amongst the best in the industry. NHI outperforms 90.70% of its industry peers.
NHI has a Quick Ratio of 3.23. This indicates that NHI is financially healthy and has no problem in meeting its short term obligations.
Looking at the Quick ratio, with a value of 3.23, NHI belongs to the top of the industry, outperforming 90.70% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 3.23
Quick Ratio 3.23
NHI Yearly Current Assets VS Current LiabilitesNHI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M

4

3. Growth

3.1 Past

The earnings per share for NHI have decreased by -1.31% in the last year.
The Earnings Per Share has been decreasing by -4.49% on average over the past years.
The Revenue has been growing slightly by 7.52% in the past year.
The Revenue has been growing slightly by 1.05% on average over the past years.
EPS 1Y (TTM)-1.31%
EPS 3Y6.89%
EPS 5Y-4.49%
EPS Q2Q%4.23%
Revenue 1Y (TTM)7.52%
Revenue growth 3Y3.92%
Revenue growth 5Y1.05%
Sales Q2Q%9.55%

3.2 Future

NHI is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 4.12% yearly.
NHI is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 19.04% yearly.
EPS Next Y4.9%
EPS Next 2Y5.4%
EPS Next 3Y4.12%
EPS Next 5YN/A
Revenue Next Year10.95%
Revenue Next 2Y11.35%
Revenue Next 3Y10.66%
Revenue Next 5Y19.04%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
NHI Yearly Revenue VS EstimatesNHI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 200M 400M 600M 800M
NHI Yearly EPS VS EstimatesNHI Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 1 2 3 4

3

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 24.15, the valuation of NHI can be described as rather expensive.
75.19% of the companies in the same industry are more expensive than NHI, based on the Price/Earnings ratio.
Compared to an average S&P500 Price/Earnings ratio of 26.35, NHI is valued at the same level.
The Price/Forward Earnings ratio is 21.96, which indicates a rather expensive current valuation of NHI.
Based on the Price/Forward Earnings ratio, NHI is valued cheaply inside the industry as 86.05% of the companies are valued more expensively.
When comparing the Price/Forward Earnings ratio of NHI to the average of the S&P500 Index (22.20), we can say NHI is valued inline with the index average.
Industry RankSector Rank
PE 24.15
Fwd PE 21.96
NHI Price Earnings VS Forward Price EarningsNHI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

NHI's Enterprise Value to EBITDA ratio is a bit more expensive when compared to the industry. NHI is more expensive than 78.29% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 17.27
NHI Per share dataNHI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
NHI has an outstanding profitability rating, which may justify a higher PE ratio.
PEG (NY)4.93
PEG (5Y)N/A
EPS Next 2Y5.4%
EPS Next 3Y4.12%

4

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 4.93%, NHI is a good candidate for dividend investing.
NHI's Dividend Yield is comparable with the industry average which is at 6.93.
NHI's Dividend Yield is rather good when compared to the S&P500 average which is at 2.40.
Industry RankSector Rank
Dividend Yield 4.93%

5.2 History

The dividend of NHI decreases each year by -3.12%.
NHI has paid a dividend for at least 10 years, which is a reliable track record.
NHI has decreased its dividend in the last 3 years.
Dividend Growth(5Y)-3.12%
Div Incr Years0
Div Non Decr Years2
NHI Yearly Dividends per shareNHI Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1 2 3 4

5.3 Sustainability

112.40% of the earnings are spent on dividend by NHI. This is not a sustainable payout ratio.
DP112.4%
EPS Next 2Y5.4%
EPS Next 3Y4.12%
NHI Yearly Income VS Free CF VS DividendNHI Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M -200M
NHI Dividend Payout.NHI Dividend Payout, showing the Payout Ratio.NHI Dividend Payout.PayoutRetained Earnings

NATL HEALTH INVESTORS INC

NYSE:NHI (5/28/2025, 3:47:59 PM)

72.685

-0.75 (-1.03%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryDiversified REITs
Earnings (Last)05-05 2025-05-05/amc
Earnings (Next)08-04 2025-08-04/amc
Inst Owners71%
Inst Owner Change2.5%
Ins Owners1.94%
Ins Owner Change4.36%
Market Cap3.39B
Analysts76.67
Price Target82.47 (13.46%)
Short Float %3.2%
Short Ratio5.86
Dividend
Industry RankSector Rank
Dividend Yield 4.93%
Yearly Dividend3.51
Dividend Growth(5Y)-3.12%
DP112.4%
Div Incr Years0
Div Non Decr Years2
Ex-Date06-30 2025-06-30 (0.9)
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)3.28%
Min EPS beat(2)-0.09%
Max EPS beat(2)6.65%
EPS beat(4)2
Avg EPS beat(4)0.9%
Min EPS beat(4)-12.08%
Max EPS beat(4)9.11%
EPS beat(8)5
Avg EPS beat(8)5.07%
EPS beat(12)6
Avg EPS beat(12)-8.12%
EPS beat(16)6
Avg EPS beat(16)-19.11%
Revenue beat(2)2
Avg Revenue beat(2)3.92%
Min Revenue beat(2)3.52%
Max Revenue beat(2)4.31%
Revenue beat(4)4
Avg Revenue beat(4)3.85%
Min Revenue beat(4)3.42%
Max Revenue beat(4)4.31%
Revenue beat(8)7
Avg Revenue beat(8)2.47%
Revenue beat(12)9
Avg Revenue beat(12)-0.28%
Revenue beat(16)10
Avg Revenue beat(16)-0.58%
PT rev (1m)-1.57%
PT rev (3m)0%
EPS NQ rev (1m)-3.07%
EPS NQ rev (3m)-3.48%
EPS NY rev (1m)-0.74%
EPS NY rev (3m)-1.37%
Revenue NQ rev (1m)0.66%
Revenue NQ rev (3m)-3.09%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-3.44%
Valuation
Industry RankSector Rank
PE 24.15
Fwd PE 21.96
P/S 9.9
P/FCF N/A
P/OCF 15.9
P/B 2.38
P/tB 2.38
EV/EBITDA 17.27
EPS(TTM)3.01
EY4.14%
EPS(NY)3.31
Fwd EY4.55%
FCF(TTM)-0.06
FCFYN/A
OCF(TTM)4.57
OCFY6.29%
SpS7.35
BVpS30.55
TBVpS30.55
PEG (NY)4.93
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 5.07%
ROE 9.89%
ROCE 7.04%
ROIC 5.56%
ROICexc 5.85%
ROICexgc 5.9%
OM 55.64%
PM (TTM) 41.13%
GM 84.22%
FCFM N/A
ROA(3y)4.46%
ROA(5y)4.65%
ROE(3y)8.71%
ROE(5y)9.16%
ROIC(3y)5.45%
ROIC(5y)5.5%
ROICexc(3y)5.5%
ROICexc(5y)5.56%
ROICexgc(3y)5.53%
ROICexgc(5y)5.6%
ROCE(3y)6.9%
ROCE(5y)6.97%
ROICexcg growth 3Y3.22%
ROICexcg growth 5Y0.14%
ROICexc growth 3Y3.22%
ROICexc growth 5Y0.15%
OM growth 3Y-3.37%
OM growth 5Y-4.05%
PM growth 3Y3.19%
PM growth 5Y-4%
GM growth 3Y-4.37%
GM growth 5Y-3.06%
F-Score6
Asset Turnover0.12
Health
Industry RankSector Rank
Debt/Equity 0.89
Debt/FCF N/A
Debt/EBITDA 4.79
Cap/Depr 295.5%
Cap/Sales 62.98%
Interest Coverage 3.45
Cash Conversion 80.86%
Profit Quality N/A
Current Ratio 3.23
Quick Ratio 3.23
Altman-Z 1.74
F-Score6
WACC7.82%
ROIC/WACC0.71
Cap/Depr(3y)89.28%
Cap/Depr(5y)89.91%
Cap/Sales(3y)19.27%
Cap/Sales(5y)20.88%
Profit Quality(3y)140.72%
Profit Quality(5y)127.73%
High Growth Momentum
Growth
EPS 1Y (TTM)-1.31%
EPS 3Y6.89%
EPS 5Y-4.49%
EPS Q2Q%4.23%
EPS Next Y4.9%
EPS Next 2Y5.4%
EPS Next 3Y4.12%
EPS Next 5YN/A
Revenue 1Y (TTM)7.52%
Revenue growth 3Y3.92%
Revenue growth 5Y1.05%
Sales Q2Q%9.55%
Revenue Next Year10.95%
Revenue Next 2Y11.35%
Revenue Next 3Y10.66%
Revenue Next 5Y19.04%
EBIT growth 1Y7.59%
EBIT growth 3Y0.41%
EBIT growth 5Y-3.04%
EBIT Next Year55.52%
EBIT Next 3Y18.19%
EBIT Next 5Y11.78%
FCF growth 1Y-101.94%
FCF growth 3Y-26.33%
FCF growth 5Y24.64%
OCF growth 1Y20.17%
OCF growth 3Y-0.5%
OCF growth 5Y-2.92%